PMC:7180007 / 14431-14566
Annnotations
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T110 | 0-5 | CHEBI:23888;CHEBI:23888 | denotes | Drugs |
| T111 | 62-77 | CHEBI:67197;CHEBI:67197 | denotes | endocannabinoid |
| T5899 | 0-5 | CHEBI:23888;CHEBI:23888 | denotes | Drugs |
| T92896 | 62-77 | CHEBI:67197;CHEBI:67197 | denotes | endocannabinoid |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T10 | 62-77 | Chemical | denotes | endocannabinoid | http://purl.obolibrary.org/obo/CHEBI_67197 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T97 | 0-135 | Sentence | denotes | Drugs that influence glutamatergic, adrenergic, serotonergic, endocannabinoid systems and various neuropeptide are generally preferred. |